title: Gout--is Lee's 2008 risk:benefit conclusion for benzbromarone hepatotoxicity still relevant today?
authors.affiliation: Te Arai BioFarma Ltd, Herne Bay, Auckland, New Zealand.
authors.forename: Lance
authors.initials: L
authors.lastname: Gravatt
mesh_terms: D000818:Animals; D001553:Benzbromarone / Q000627:therapeutic use*; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D014528:Uricosuric Agents / Q000627:therapeutic use*
chemical_list: D014528:Uricosuric Agents; D001553:Benzbromarone